Navigation Links
Drinking Green Tea May Protect Eyes

Researchers confirm that beneficial ingredients penetrate eye tissue

SATURDAY, April 24 (HealthDay News) -- Beneficial ingredients in green tea penetrate into the tissues of the eye and may help protect against glaucoma and other eye diseases, says a new study.

Researchers analyzed eye tissue from rats that drank green tea and found that the lens, retina and other tissues absorbed significant amounts of green tea catechins, which are antioxidants believed to protect the eye. Catechins include vitamin C, vitamin E, lutein and zeaxanthin.

The action of the green tea catechins in reducing harmful oxidative stress in the eyes lasted for up to 20 hours.

"Our results indicate that green tea consumption could benefit the eye against oxidative stress," wrote Chi Pui Pang of the department of ophthalmology and visual sciences at the Chinese University of Hong Kong, Hong Kong Eye Hospital, and colleagues.

The findings are published in the Journal of Agricultural and Food Chemistry.

Prior to this study, it wasn't known if the catechins in green tea traveled from the digestive system into the tissues of eyes.

More information

The U.S. National Library of Medicine has more about green tea.

-- Robert Preidt

SOURCE: American Chemical Society, news release, April 21, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Smoking May Erase Heart Benefits of Light Drinking
2. Smoking may counteract benefit of moderate drinking on stroke risk
3. Teen Drinking May Boost Breast Problems Later
4. Adolescent drinking adds to risk of breast disease, breast cancer
5. Your Social Network Affects Your Drinking Habits
6. Heavy Daily Drinking Linked to Worse Health
7. Underage Drinking Soars in U.S.
8. Binge drinking doesnt affect next-day student test-taking
9. Light Drinking Good for the Heart
10. Progress In Access To Safe Drinking-Water; Sanitation Needs Greater Efforts
11. Obesity, Drinking a Double Threat to the Liver
Post Your Comments:
(Date:12/1/2015)... ... ... ClinicoEconomics and Outcomes Research has published the ... ”. , As corresponding author Dr Ankita Modi says “Pre-existing gastrointestinal events may ... a large US managed care database, women aged 55 years or older with ...
(Date:12/1/2015)... ... December 01, 2015 , ... Physicians’ Education Resource®, ... (CME), today announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will ... detection and treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Growth in ... part due to decreases in utilization of hospital and nonhospital care, according to a ... CompScope™ Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the ... North America Annual Meeting from November 29 to December 4, 2015. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage ... (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced ... Radiological Society of North America (RSNA) 2015 annual meeting through December 3 in ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... , December 1, 2015 Russia ... III clinical trials. 70% of new drugs registered in Europe ... in Russia . --> Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a ...
(Date:12/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: CYTR ... oncology, today announced that it has reached its enrollment ... Phase 3 clinical trial of aldoxorubicin in patients with ... to be completed in Q1 2016. The Phase 3 trial ... Special Protocol Assessment from the FDA at 79 sites ...
Breaking Medicine Technology: